Advertisement

Journal of Cancer Education

, 23:214 | Cite as

Feasibility of an ovarian cancer quality-of-life psychoeducational intervention

  • Shirley Otis-Green
  • Betty Ferrell
  • Virginia Sun
  • Maren Spolum
  • Robert Morgan
  • Deborah MacDonald
Articles

Abstract

Background. Diagnosis of ovarian cancer often portends a poor prognosis with significant quality-of-life (QOL) concerns. Method. We report on a pilot study that tested the feasibility of a structured, ovarian cancer psychoeducational intervention (OCPI). Patients (N=33) were randomly assigned to either the control or OCPI study arms in which those in the intervention arm received 4 sequential, structured, in-person educational sessions. Data were collected at the time of accrual and at 1 and 3 months postaccrual. Results. This study demonstrated the feasibility of a structured psychoeducational program in an outpatient clinical setting. Conclusion. Study findings underscore the importance of developing interventions that address the 4 QOL domains impacted by ovarian cancer and support initiating a comprehensive psychoeducational intervention earlier in the course of illness.

Keywords

Ovarian Cancer Ovarian Cancer Patient Distress Thermometer Psychoeducational Intervention Prophylactic Oophorectomy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2007. CA Cancer J Clin. 2007:57:43–66.CrossRefPubMedGoogle Scholar
  2. 2.
    Markman M. Management of ovarian cancer. An impressive history improvement in survival and quality of life. Oncology (Williston Park) 2006;20:347–354; 357–358, 364.Google Scholar
  3. 3.
    Jemal A, Murray T, Samuels A, et al. Cancer Statistics, 2003. CA Cancer J Clin. 2003;53:5–26.CrossRefPubMedGoogle Scholar
  4. 4.
    McQuellon RP, Loggie BW, Lehman AB, et al. Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol. 2003;10:155–162.CrossRefPubMedGoogle Scholar
  5. 5.
    Wenzel LB, Huang HQ, Armstrong DK, et al. Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol. 2007;25:437–443.CrossRefPubMedGoogle Scholar
  6. 6.
    Hess L, Alberts D. The role of intraperitoneal therapy in advanced ovarian cancer. Oncology 2007;21:227–232.PubMedGoogle Scholar
  7. 7.
    Armstrong DK, Brady MF. Intraperitoneal therapy for ovarian cancer: a treatment ready for prime time. J Clin Oncol. 2006;24:4531–4533.CrossRefPubMedGoogle Scholar
  8. 8.
    Ferrell BR, Smith SL, Cullinane CA, et al. Psychological well being and quality of life in ovarian cancer survivors. Cancer. 2003b;98:1061–1071.CrossRefPubMedGoogle Scholar
  9. 9.
    Howell D, Fitch MI, Deane KA. Women’s experiences with recurrent ovarian cancer. Cancer Nurs. 2003;26:10–17.CrossRefPubMedGoogle Scholar
  10. 10.
    Maughan K. Specific keynote: in the shadow of illness-supporting women with ovarian cancer. Gynecol Oncol. 2003;88(pt 2):S129-S133, S134–S135.CrossRefPubMedGoogle Scholar
  11. 11.
    Swenson MM, MacLeod JS, Williams SD, et al. Quality of living among ovarian germ cell cancer survivors: a narrative analysis. Oncol Nurs Forum [serial online]. 2003;30(3):380. Available from: Oncology Nursing Society: http://www.ons.org/publications/journals/ONF/Volume30/Issue3/300338.aspAccessed November 4, 2008.Google Scholar
  12. 12.
    Wenzel LB, Donnelly JP, Fowler JM, et al. Resilience, reflection, and residual stress in ovarian cancer survivorship: a gynecologic oncology group study. Psycho-oncology 2002;11:142–153.CrossRefPubMedGoogle Scholar
  13. 13.
    Tannock IF, Ahles TA, Ganz PA, et al. Cognitive impairments associated with chemotherapy for cancer: report of a workshop. J Clin Oncol. 2004;22:2233–2239.CrossRefPubMedGoogle Scholar
  14. 14.
    Doyle C, Crump M, Pintilie M, et al. Does palliative chemotherapy palliated: evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer. J Clin Oncol. 2001;19:1266–1274.PubMedGoogle Scholar
  15. 15.
    Lakusta CM, Atkinson MJ, Robinson JW, et al. Quality of life in ovarian cancer patients receiving chemotherapy. Gynecol Oncol. 2001;81:490–495.CrossRefPubMedGoogle Scholar
  16. 16.
    Fitch MI, Gray RE, Franssen E. Women’s perspectives regarding the impact of ovarian cancer: implications for nursing. Cancer Nurs. 2000;23:359–366.CrossRefPubMedGoogle Scholar
  17. 17.
    Ferrell BR, Smith SL, Cullinane CA, et al. Symptom concerns of women with ovarian cancer. J Pain Symptom Manage. 2003a; 25:528–538CrossRefPubMedGoogle Scholar
  18. 18.
    Ersek M, Ferrell BR, Dow KH, et al. Quality of life in women with ovarian cancer. West J Nurs Res. 1997;19:334–350.CrossRefPubMedGoogle Scholar
  19. 19.
    Anderson B. Quality of life in progressive ovarian cancer. Gynecol Oncol. 1994;55 (Pt 2):S151-S155.PubMedGoogle Scholar
  20. 20.
    Carroll-Johnson RM, Gorman LM, Bush NJ. Psychological Nursing Care Along the Cancer Continuum. Pittsburgh, PA: Oncology Nursing Press; 1998.Google Scholar
  21. 21.
    Hamilton AB. Psychological aspects of ovarian cancer. Cancer Invest, 1999;17:335–341.CrossRefPubMedGoogle Scholar
  22. 22.
    National Institute of Health. Consensus Development Conference Statement. Ovarian cancer: screening, treatment, and follow-up. Gynecol Oncol. 1994;55(pt 2):S4-S14.Google Scholar
  23. 23.
    Lutgendorf SK, Anderson B, Ullrich P, et al. Quality of life and mood in women with gynecologic cancer: a one year prospective study. Cancer. 2002;94:131–140.CrossRefPubMedGoogle Scholar
  24. 24.
    Houck K, Avis NE, Gallant JM, et al. Quality of life in advanced ovarian cancer: identifying specific concerns. J Palliat Med. 1999;2:397–402.CrossRefPubMedGoogle Scholar
  25. 25.
    Weitzel J, MacDonald, DJ. Genetic testing for ovarian cancer. Qual Life Res. 1998;6:101–108.Google Scholar
  26. 26.
    Di Prospero LS, Seminsky M, Honeyford J, et al. Psychosocial issues-following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey. Can Med Assoc J. 2001;164:1005–1009.Google Scholar
  27. 27.
    Ferrell BR, Grant M, Funk B, et al. Quality of life in breast cancer survivors: implications for developing support services. Oncol Nurs Forum. 1998;25:887–895.PubMedGoogle Scholar
  28. 28.
    Ferrell BR, Grant M, Funk B, et al. Quality of life in breast cancer survivors as identified by focus groups. Psycho-oncology. 1997;6:13–23.CrossRefPubMedGoogle Scholar
  29. 29.
    Hallowell N. A qualitative study of the information needs of high-risk women undergoing prophylactic oophorectomy. Psycho-oncology. 2000;9:486–495.CrossRefPubMedGoogle Scholar
  30. 30.
    Meiser B, Tiller K, Glesson MA, et al. Psychological impact of prophylactic oophorectomy in women at increased risk for ovarian cancer. Psycho-oncology. 2000;9:496–503.CrossRefPubMedGoogle Scholar
  31. 31.
    Ferrell BR, Grant M, Funk B, et al. Quality of life in breast cancer. Part II: psychological and spiritual well being. Cancer Nurs 1997;21:1–9.Google Scholar
  32. 32.
    Kemp C. Spiritual care interventions. In: Ferrell B, Coyle N, eds. Textbook of Palliative Nursing. New York, NY: Oxford University Press;2001:407–414.Google Scholar
  33. 33.
    Brown-Saltzman KA. Tending the spirit. Oncol Nurs Forum. 1994;21:1001–1006.PubMedGoogle Scholar
  34. 34.
    Burton LA. The spiritual dimension of palliative care. Semin Oncol Nurs. 1998;14:121–128.CrossRefPubMedGoogle Scholar
  35. 35.
    Dow KH, Ferrell BR, Haberman MR, et al. The meaning of quality of life in cancer survivorship. Oncol Nurs Forum 1999;26:519–528.PubMedGoogle Scholar
  36. 36.
    Ferrell BR, Smith SL, Juarez G, et al. Meaning of illness and spirituality in ovarian cancer survivors. Oncol Nurs Forum 2003d;30(2):249–257.CrossRefPubMedGoogle Scholar
  37. 37.
    Payne DK, Massie MJ. Depression and anxiety. In: Berger A, Portenoy RK, Weisman DE, eds. Supportive Oncology: Philadelphia, PA: Lippencott-Raven; 1998:497–512.Google Scholar
  38. 38.
    Fry A, Busby-Earle C, Rush R, et al. Prophylactic oophorectomy versus screening: psychosocial outcomes in women at increased risk of ovarian cancer. Psycho-oncology 2001;10:231–241.CrossRefPubMedGoogle Scholar
  39. 39.
    Hughes C, Lerman C, Schwartz M, et al. All in the family: evaluation of the process and content of sisters’ communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet. 2002;107:143–150.CrossRefPubMedGoogle Scholar
  40. 40.
    Ferrell BR, Smith SL, Ervin KS, et al. A qualitative analysis of social concerns of women with ovarian cancer. Psycho-oncology. 2003c;12:647–663.CrossRefPubMedGoogle Scholar
  41. 41.
    Ferrell BR, Cullinane CA, Ervine K, et al. Perspectives on the impact of ovarian cancer: women’s views of quality of life. Oncol Nurs Forum. 2005;32(6):1143–1149.CrossRefPubMedGoogle Scholar
  42. 42.
    Ferrell BR, Dow KH, Grant M. Measurement of the quality of life in cancer survivors. Qual Life Res 1995;4:523–531.CrossRefPubMedGoogle Scholar
  43. 43.
    Mishel MH, Sorenson DS. Uncertainty in gynecological cancer: a test of the mediating functions of mastery and coping. Nurs Res. 1991;40:167–171.PubMedGoogle Scholar
  44. 44.
    Donovan KA, Jacobsen PB, Holland JC, et al. Psychometric properties and correlates of Distress Thermometer Scores. Psycho-oncology. 2004;13:S16.Google Scholar
  45. 45.
    Mishel MH. The measurement of uncertainty in illness. Nurs Res. 1981;30:258–263.CrossRefPubMedGoogle Scholar
  46. 46.
    Mishel MH. Uncertainty in illness. Image J Nurs Sch. 1988;20:225–232.CrossRefPubMedGoogle Scholar
  47. 47.
    Mishel MH, Braden CJ. Finding meaning: antecedents of uncertainty in illness. Nurs Res. 1988;37:98–103.CrossRefPubMedGoogle Scholar
  48. 48.
    Mishel M. Uncertainty in Illness Scales Manual. Chapel Hill, NC: University of North Carolina; 1997.Google Scholar

Copyright information

© American Association for Cancer Education 2008

Authors and Affiliations

  • Shirley Otis-Green
    • 1
  • Betty Ferrell
    • 1
  • Virginia Sun
    • 1
  • Maren Spolum
    • 1
  • Robert Morgan
    • 1
  • Deborah MacDonald
    • 1
  1. 1.City of Hope National Medical CenterNursing Research and EducationDuarte

Personalised recommendations